Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Regeneron Pharmaceuticals
(NQ:
REGN
)
982.29
+14.31 (+1.48%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Regeneron Pharmaceuticals
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
31
32
Next >
2 Biotech Stocks You Can Buy and Hold for the Next Decade
June 21, 2023
Gilead and Regeneron Pharmaceuticals both had triple-digit percentage growth over the past decade.
Via
The Motley Fool
How to Retire Rich: Biotech Stocks Edition
June 18, 2023
Thanks to its enormous and practically permanent relevancies, the biotech sector offers a great avenue for retirement planning stocks.
Via
InvestorPlace
How Biotech Stocks Are Revolutionizing Healthcare Investment Opportunities
June 17, 2023
The field of biotechnology has become a driving force behind groundbreaking medical advancements, offering investors the opportunity to benefit from these innovations. Here are 10 healthcare innovators...
Via
Talk Markets
EyePoint's EYP-1901 Tipped to Transform Wet AMD Market, Analyst Predicts Potential $870M Sales by 2035
June 14, 2023
JonesResearch has initiated coverage of ophthalmic biopharmaceutical company EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) with a Buy rating and
Via
Benzinga
2 Stocks to Buy No Matter What Happens in June and Beyond
June 14, 2023
A lot could go wrong in the next few months, but investors should largely ignore all that noise.
Via
The Motley Fool
18 Analysts Have This to Say About Regeneron Pharmaceuticals
June 09, 2023
Via
Benzinga
Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 10 Years
June 07, 2023
Via
Benzinga
Regeneron Pharmaceuticals Unusual Options Activity For June 05
June 05, 2023
Via
Benzinga
Regeneron Pharmaceuticals Unusual Options Activity
May 30, 2023
Via
Benzinga
3 Biotech Stocks to Sell in June Before They Crash and Burn
June 06, 2023
Investors should get out of these biotech stocks to sell now that the Covid-19 pandemic is largely over. These's worse in store for them.
Via
InvestorPlace
Wall Street Says These 2 Stocks May Double. Should You Buy Them?
June 05, 2023
Both of these stocks have declined over the past year.
Via
The Motley Fool
Regeneron Reveals Updated Data From Multiple Myeloma Study, Showing Response Rate Of 71%
May 26, 2023
Via
Benzinga
Regeneron Pharmaceuticals Unusual Options Activity For May 25
May 25, 2023
Via
Benzinga
Here's How Much $100 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth Today
May 22, 2023
Via
Benzinga
A Good Week For The Market But A Pause In The Biotech Rally
May 22, 2023
Healthcare stocks have been lagging in 2023 with the XLV down 1.97% MTD and 3.34% YTD with CVS and UNH contributing to the weakness.
Via
Talk Markets
This Is What Whales Are Betting On Regeneron Pharmaceuticals
May 19, 2023
Via
Benzinga
How Is The Market Feeling About Regeneron Pharmaceuticals?
May 15, 2023
Via
Benzinga
Looking At Regeneron Pharmaceuticals's Recent Unusual Options Activity
May 08, 2023
Via
Benzinga
If You Invested $100 In This Stock 10 Years Ago, You Would Have $300 Today
May 05, 2023
Via
Benzinga
Sanofi-Regeneron Highlight Dupixent Data, Say Drug Benefit Was Swift, Sustained
May 22, 2023
Via
Benzinga
The 7 Growth Stocks You Need to Own Now for Maximum Returns
May 17, 2023
If you still want to stick around in the market for max returns, these growth stocks to buy should be intriguing for speculators.
Via
InvestorPlace
AI-Run ETF Dumps Apple In Favor Of This Chip Stock And Hints At New Opportunity Brewing In Market
May 12, 2023
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
May 10, 2023
Via
Benzinga
Why Regeneron Pharmaceuticals Stock Is Tanking Today
May 04, 2023
Investors are worried about Eylea's falling sales.
Via
The Motley Fool
Regeneron Pharma Dives As Competition Undercuts Its Biggest Moneymaker
May 04, 2023
Eylea sales fell and missed expectations in the U.S.
Via
Investor's Business Daily
Regeneron Pharmaceuticals Unusual Options Activity
May 03, 2023
Via
Benzinga
2 Cathie Wood Stocks That Can Get You Through Any Recession
May 10, 2023
Shares of both companies moved higher even as the stock market fell last year.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
May 09, 2023
Via
Benzinga
Market Rally Finishes Strong; Regional Banks, Fed Rate Hike, Jobs Report, Apple In Focus: Weekly Review
May 05, 2023
The major indexes retreated for most of the week on banking fears,
Via
Investor's Business Daily
Why Regeneron Pharmaceuticals Shares Are Trading Lower Today
May 04, 2023
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) earned adjusted EPS of $10.09, down 12% Y/Y, beating
Via
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
31
32
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.